Literature DB >> 29599276

Immune Modulation as a Treatment for Abdominal Aortic Aneurysms.

S Keisin Wang1, Michael P Murphy2.   

Abstract

Entities:  

Keywords:  angiotensin II; aortic aneurysm, abdominal; doxycycline; matrix metalloproteinases; risk factors

Mesh：

Year:  2018        PMID： 29599276      PMCID： PMC5880296          DOI： 10.1161/CIRCRESAHA.118.312870

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  9 in total

1.  Osteopontin may be a driver of abdominal aortic aneurysm formation.

Authors:  S Keisin Wang; Linden A Green; Ashley R Gutwein; Alok K Gupta; Clifford M Babbey; Raghu L Motaganahalli; Andres Fajardo; Michael P Murphy
Journal:  J Vasc Surg       Date:  2018-02-03       Impact factor: 4.268

2.  Association between osteopontin and human abdominal aortic aneurysm.

Authors:  Jonathan Golledge; Juanita Muller; Neil Shephard; Paula Clancy; Linda Smallwood; Corey Moran; Anthony E Dear; Lyle J Palmer; Paul E Norman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-12-14       Impact factor: 8.311

3.  Rationale and Design of the ARREST Trial Investigating Mesenchymal Stem Cells in the Treatment of Small Abdominal Aortic Aneurysm.

Authors:  S Keisin Wang; Linden A Green; Ashley R Gutwein; Natalie A Drucker; Raghu L Motaganahalli; Andres Fajardo; Clifford M Babbey; Michael P Murphy
Journal:  Ann Vasc Surg       Date:  2017-09-13       Impact factor: 1.466

4.  Haemodynamics and stresses in abdominal aortic aneurysms: A fluid-structure interaction study into the effect of proximal neck and iliac bifurcation angle.

Authors:  Corey J Drewe; Louis P Parker; Lachlan J Kelsey; Paul E Norman; Janet T Powell; Barry J Doyle
Journal:  J Biomech       Date:  2017-06-27       Impact factor: 2.712

5.  Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells.

Authors:  Nicola Gagliani; Chiara F Magnani; Samuel Huber; Monica E Gianolini; Mauro Pala; Paula Licona-Limon; Binggege Guo; De'Broski R Herbert; Alessandro Bulfone; Filippo Trentini; Clelia Di Serio; Rosa Bacchetta; Marco Andreani; Leonie Brockmann; Silvia Gregori; Richard A Flavell; Maria-Grazia Roncarolo
Journal:  Nat Med       Date:  2013-04-28       Impact factor: 53.440

6.  Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6.

Authors:  Ryang Hwa Lee; Andrey A Pulin; Min Jeong Seo; Daniel J Kota; Joni Ylostalo; Benjamin L Larson; Laura Semprun-Prieto; Patrice Delafontaine; Darwin J Prockop
Journal:  Cell Stem Cell       Date:  2009-07-02       Impact factor: 24.633

7.  Elastin fragments drive disease progression in a murine model of emphysema.

Authors:  A McGarry Houghton; Pablo A Quintero; David L Perkins; Dale K Kobayashi; Diane G Kelley; Luiz A Marconcini; Robert P Mecham; Robert M Senior; Steven D Shapiro
Journal:  J Clin Invest       Date:  2006-02-09       Impact factor: 14.808

Review 8.  Exploring autoimmunity in the pathogenesis of abdominal aortic aneurysms.

Authors:  Tiffany W Chang; Adam S A Gracon; Michael P Murphy; David S Wilkes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-06-26       Impact factor: 4.733

9.  Lifestyle and Risk of Screening-Detected Abdominal Aortic Aneurysm in Men.

Authors:  Otto Stackelberg; Alicja Wolk; Ken Eliasson; Anders Hellberg; Adam Bersztel; Susanna C Larsson; Nicola Orsini; Anders Wanhainen; Martin Björck
Journal:  J Am Heart Assoc       Date:  2017-05-10       Impact factor: 5.501
  9 in total
  2 in total

Review 1.  Tryptophan Catabolism and Inflammation: A Novel Therapeutic Target For Aortic Diseases.

Authors:  Tharmarajan Ramprasath; Young-Min Han; Donghong Zhang; Chang-Jiang Yu; Ming-Hui Zou
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

2.  Association between abdominal aortic aneurysms and alcohol-related diseases.

Authors:  Ling-Yuan Li; Wu-Chien Chien; Jen-Chun Wang; Nian-Sheng Tzeng; Chi-Hsiang Chung; Chih-Yuan Lin; Shih-Hung Tsai
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.